SK Biopharmaceuticals Co., Ltd. announced a private placement of 10,000,000 common shares at KRW 10,000 per share for gross proceeds of KRW 100,000,000,000 with existing investor SK Holdings Co. Ltd. on December 19, 2013. The shares were issued at premium of KRW 9,500 per share. The par value of the shares is KRW 500 per share. The company will issue 0.25 new shares for every existing share held. The subscription period will start and end on January 20, 2014. Upon completion of the transaction, the investor will continue to hold a 100% stake in the company. The payment date will be January 20, 2014. The board of directors of the company has approved the transaction.

On January 20, 2014, SK Biopharmaceuticals Co., Ltd. closed the transaction.